Incannex Healthcare (IXHL) Asset Writedowns and Impairment (2025)
Incannex Healthcare (IXHL) posted quarterly Asset Writedowns and Impairment of -$49000.0 for Q2 2025, down 2550.0% on a QoQ basis from $2000.0 in Q1 2025.
Incannex Healthcare (IXHL) Asset Writedowns and Impairment (2025) Analysis & Trends
Incannex Healthcare (IXHL) has reported Asset Writedowns and Impairment for 1 consecutive years, with -$49000.0 the latest figure, recorded in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.50 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.20 Bn | 21.05 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.58 Bn | 12.15 Bn | 785.00 Mn |
| 10 | Incannex Healthcare | 36.67 Mn | 36.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -49,000.00 |
| Jun 30, 2025 | -49,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |